AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimfit M1 Tablet

Prescription Icon
Prescription Required

Marketer

Biosync Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimfit M1 Tablet

Diabetic patients often utilize the anti-diabetic medication, Glimfit M1, a dual-medicine formulation for managing type 2 diabetes in adults. This medication effectively regulates blood glucose. Administer Glimfit M1 with meals, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is vital; premature discontinuation, without medical consultation, can elevate blood sugar, potentially leading to complications like kidney failure, vision impairment, neuropathy, and limb loss. Remember, Glimfit M1 is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry a fast-acting glucose source (e.g., sugary snacks or juice), and avoid alcohol to mitigate this risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your physician of any prior heart conditions before commencing treatment; pregnancy or breastfeeding necessitates medical consultation prior to use. Regular blood sugar monitoring and blood tests (to assess blood cell counts and liver function) are recommended by your doctor.

Primary Ingredients of Glimfit M1 Tablet

The provided text is "undefined," therefore no rewriting is possible.

Uses of Glimfit M1 Tablet

Managing type 2 diabetes

Major Benefits of Glimfit M1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimfit M1 Tablet with a meal.

Common Side effects of Glimfit M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimfit M1 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimfit M1 Tablet with a meal.

How Glimfit M1 Tablet works:

Glimfit M1 Tablet combines glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimfit M1 Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimfit M1 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimfit M1 Tablet are incompatible; evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimfit M1 Tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before administering. Glimfit M1 Tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimfit M1 Tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, Glimfit M1 Tablets are contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimfit M1 Tablet :

Should you forget a Glimfit M1 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimfit M1 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimfit M1 Tablet

Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication properly. Prevent access by children, pets, and others.
Glimfit M1 Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction is a significant risk for individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glimfit M1 Tablet and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimfit M1 Tablet, treat type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when coupled with a suitable diet and consistent physical activity. Glimepiride functions by stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin's action involves decreasing hepatic glucose production and increasing insulin responsiveness. This dual medication is unsuitable for managing type 1 DM.
Glimfit M1 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimfit M1 Tablet use can indeed lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum annually, has been proposed by some studies.
Glimfit M1 Tablets may induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar can include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimfit M1 Tablet and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimfit M1 Tablet
37
MRP 46
18% off